Clinical Trial

Prevalence and Clinical Implications of HPV Infection in Male IBD Patients

Study acronym: PAPIMALE
Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated September 12, 2025 (before its estimated January 31, 2026 completion). Its status may not reflect the trial's current state.
Summary
The study aims at describing the prevalence of Human Papillomavirus (HPV) infection in anal and oral samples of men with Inflammatory Bowel Disease (IBD) and detecting risk factors for the infection.
Protocol Amendment History 3 amendments
This ClinicalTrials.gov record has been amended 3 times since 2023-06-10; most recent amendment 2025-09-08.
Status change: Not Yet Recruiting → Recruiting 2024-02-14
Trial Details
NCT Number NCT05911750
Lead Sponsor Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau
Conditions HPV Infection, Dysplasia Anus, Oral Cavity Disease
Enrollment 384 participants
Start Date 2023-02-12
Primary Completion 2026-01-31 (estimated)
Study Completion 2026-06-01 (estimated)
Updated on ClinicalTrials.gov 2025-09-12